Caris Life Sciences
@carisls
Caris Life Sciences, the precision medicine pioneer, develops and delivers innovative solutions to revolutionize healthcare and improve the human condition.
ID: 274132854
https://www.carislifesciences.com/ 29-03-2011 19:59:38
6,6K Tweet
23,23K Followers
3,3K Following
#ProstateCancer diversity revealed: AR and neuroendocrine signatures. Yu-Wei Chen, MD, MS UC San Diego Health Moores Cancer Center joins Alicia Morgans, MD, MPH Dana-Farber to discuss his research using the #Caris database underscoring the potential of molecular diagnostics > bit.ly/3Z2dX5z Caris Life Sciences
What is the role of NEDD9 in lung cancer? Hear Dr. Julia Judd from Fox Chase Cancer Center discuss the impact of NEDD9 gene expression on outcomes in 1,800+ cases of aggressive dual KRAS- and STK11-mutant NSCLC. #WCLC24 carislifesciences.com/iaslc-wclc-202…
Does HER3 expression have an impact on non-EGFR-mutant NSCLC? Join Dr. Brinda Gupta from Georgetown Lombardi as she explores HER3 expression in a cohort of >52k NSCLC samples from Caris. #WCLC24 ow.ly/Sih450TilP0
Cell-surface protein SEZ6 is a potential ADC target in SCLC and neuroendocrine (NE) tumors. Hear @JenniferMarksMD from Georgetown Lombardi discuss molecular profiles of SEZ6 and other relevant biomarkers in 3,500+ SCLC and NE tumors from Caris. #WCLC24
What treatment strategy is most effective in advanced large cell neuroendocrine tumors (LCNEC)? Amin Nassar, MD from Yale Department of Immunobiology shows that chemo and immunotherapy have similar effectiveness, but IO is significantly less toxic. #WCLC24
Does the immune environment affect the effectiveness of immunotherapy in the rare lung cancer LUAS? Hear Dr. Matthew Lee Montefiore Health System Albert Einstein College of Medicine - Official discuss how the LUAS immune environment differs from other classes of NSCLC. #WCLC24